|
Volumn 68, Issue 2, 2011, Pages 78-81
|
[High-dose chemotherapy and autologous stem cell transplantation in multiple myeloma patients--single center experience].;Wysokodawkowana chemioterapia z przeszczepieniem autologicznych komórek macierzystych u chorych na szpiczaka plazmocytowego--wyniki analizy jednoośrodkowej.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
MELPHALAN;
THALIDOMIDE;
ADULT;
ARTICLE;
AUTOTRANSPLANTATION;
FEMALE;
HUMAN;
MALE;
MIDDLE AGED;
MORTALITY;
MULTIMODALITY CANCER THERAPY;
MULTIPLE MYELOMA;
PERIPHERAL BLOOD STEM CELL TRANSPLANTATION;
PROGNOSIS;
RECURRENT DISEASE;
RETROSPECTIVE STUDY;
SURVIVAL RATE;
ADULT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
COMBINED MODALITY THERAPY;
FEMALE;
HUMANS;
MALE;
MELPHALAN;
MIDDLE AGED;
MULTIPLE MYELOMA;
PERIPHERAL BLOOD STEM CELL TRANSPLANTATION;
PROGNOSIS;
RECURRENCE;
RETROSPECTIVE STUDIES;
SURVIVAL RATE;
THALIDOMIDE;
TRANSPLANTATION, AUTOLOGOUS;
|
EID: 84856404327
PISSN: 00332240
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (0)
|